0.5521
前日終値:
$0.56
開ける:
$0.5513
24時間の取引高:
496.19K
Relative Volume:
0.75
時価総額:
$15.58M
収益:
-
当期純損益:
$-12.66M
株価収益率:
-0.5011
EPS:
-1.1018
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-7.68%
1か月 パフォーマンス:
-12.32%
6か月 パフォーマンス:
-57.47%
1年 パフォーマンス:
-74.28%
Inspira Technologies Oxy B H N Ltd Stock (IINN) Company Profile
IINN を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
IINN
Inspira Technologies Oxy B H N Ltd
|
0.5521 | 15.58M | 0 | -12.66M | 0 | -1.1018 |
![]()
ABT
Abbott Laboratories
|
129.62 | 230.70B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
103.34 | 154.22B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
389.07 | 145.74B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
85.40 | 107.03B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
75.02 | 44.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Inspira Technologies Oxy B H N Ltd (IINN) 最新ニュース
Inspira Technologies Shareholders Approve Key Agenda Items at May 2025 Meeting - TipRanks
Renaissance Technologies LLC Boosts Stock Position in Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) - Defense World
Inspira’s ART100 system set for transplant validation in Israel By Investing.com - Investing.com South Africa
Stock Performance Spotlight: Inspira Technologies Oxy B.H.N. Ltd (IINN) Ends the Day at 0.58, Down by -3.78 - DWinneX
Inspira’s ART100 System Gains Approval for Organ Transplant Use in Israel - TipRanks
Inspira’s ART100 system set for transplant validation in Israel - Investing.com
INSPIRA ART100 System Approved by Israel's Largest Healthcare Provider for Use in Organ Transplant Patients - The Manila Times
Inspira Technologies' INSPIRA ART100 Approved for Clinical Validation in Organ Transplant Procedures by Israel's Largest Healthcare Provider - Nasdaq
Inspira™ Technologies Enters into Collaboration Agreement with U.S.-Based Perfusion Solution Inc. - Barchart.com
Press Release Distribution & PR Platform - ACCESS Newswire
Inspira Technologies Oxy B.H.N. Ltd (IINN) Is A Buy Stock For Small Caps – Analysts - Marketing Sentinel
Inspira Technologies (IINN) Reaches Key Milestone with VORTX Tec - GuruFocus
Inspira Technologies Achieves Breakthrough in VORTX Testing - TipRanks
Inspira Achieves above 99% Gas Exchange Efficiency in VORTX™ Technology In-Vivo Animal Testing - The Manila Times
Breakthrough Medical Tech: New Blood Oxygenation System Shows 99% Efficiency in Animal Testing - Stock Titan
Form POS AMPost-Effective amendments for registration statement - ADVFN
Inspira Technologies Receives Nasdaq Notification Regarding Minimum Bid Requirement (PR Newswire) - Aktiellt
Cardiopulmonary Bypass Equipment Market to Grow at a CAGR of ~4.14% by 2032 | DelveInsight - The Globe and Mail
Analyzing Inspira Technologies Oxy B.H.N. (NASDAQ:IINN) and Sonoma Pharmaceuticals (NASDAQ:SNOA) - Defense World
Inspira Technologies reports initial revenue from FDA-cleared life support system By Investing.com - Investing.com South Africa
Inspira Technologies reports initial revenue from FDA-cleared life support system - Investing.com India
Inspira Technologies Achieves First Revenue Milestone with INSPIRA ART100 Deployment - TipRanks
Inspira Technologies Generates First Revenues from Deployment of INSPIRA ART100 Systems - The Manila Times
Medical Breakthrough: Inspira Tech's Blood Oxygenation System Starts Generating Revenue - Stock Titan
Inspira Technologies Expands Share Offering Capacity in April 2025 - TipRanks
Inspira Technologies stock hits 52-week low at $0.57 By Investing.com - Investing.com South Africa
Inspira Technologies Announces Extraordinary General Meeting for May 2025 - TipRanks
Inspira Technologies stock hits 52-week low at $0.57 - Investing.com
Inspira Technologies Announces Successful Treatment Of First Patient With Inspira Art100 - MarketScreener
Inspira Technologies’ INSPIRA ART100 Achieves First Successful Patient Treatment - TipRanks
Inspira Technologies Announces Successful Treatment of First Patient with INSPIRA ART100 at Westchester Medical Center - The Manila Times
Inspira Technologies Oxy B.H.N. (NASDAQ:IINN) Trading Down 6.9% – Should You Sell? - Defense World
Inspira Technologies stock hits 52-week low at $0.64 - Investing.com
Inspira Technologies stock hits 52-week low at $0.64 By Investing.com - Investing.com UK
Inspira Technologies Announces Successful Installation of INSPIRA ART100 Systems in Premier U.S. Hospital - Quantisnow
Major Breakthrough: Inspira's Revolutionary Ventilation System Debuts at Leading NY Hospital - Stock Titan
Inspira Technologies' Innovative Life-Support System to be Showcased at AmSECT 63rd International Conference 2025 in San Diego - The Malaysian Reserve
Inspira Technologies Announces Sales Agreement to Boost Financial Flexibility - TipRanks
Inspira Technologies details strategic progress in respiratory care By Investing.com - Investing.com Canada
Inspira Technologies details strategic progress in respiratory care - Investing.com
Inspira Technologies Announces Major Advances in Respiratory Care - TipRanks
Inspira Technologies Releases CEO Update: Major Milestones Signal Next-Level Respiratory Care - PR Newswire
Inspira's Game-Changing Respiratory Tech Secures FDA Win, 3 More Products in Pipeline - Stock Titan
Inspira Technologies faces Nasdaq delisting over share price By Investing.com - Investing.com Australia
Inspira Technologies faces Nasdaq delisting over share price - Investing.com India
Inspira Technologies Faces Nasdaq Compliance Challenge - TipRanks
Inspira Technologies Receives Nasdaq Notification Regarding Minimum Bid Requirement - PR Newswire
IINNInspira Technologies Oxy Bhn Ltd Latest Stock News & Market Updates - Stock Titan
Inspira Technologies Reports 2024 Financial Results and Key Developments - TipRanks
Inspira Technologies Reports Full Year 2024 Financial Results and Provides Business Updates - Quantisnow
Inspira Technologies Oxy B H N Ltd (IINN) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):